Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlotta Spano

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.
NPJ Precision Oncology|October 28, 2021
GD2 CAR T cells against human glioblastomaMalvina Prapa, Chiara Chiavelli, Giulia Golinelli, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
Cytotherapy|May 12, 2025
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trialRoberto Tonelli, Francesca Pischiutta, Francesca Elice, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.
NPJ Precision Oncology|October 28, 2021
GD2 CAR T cells against human glioblastomaMalvina Prapa, Chiara Chiavelli, Giulia Golinelli, et al.
Theranostics|February 28, 2019
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic AdenocarcinomaFilippo Rossignoli, Carlotta Spano, Giulia Grisendi, et al.
Cancer Research|April 15, 2010
Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapyGiulia Grisendi, Rita Bussolari, Luigi Cafarelli, et al.
Scientific Reports|February 12, 2019
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic CancerCarlotta Spano, Giulia Grisendi, Giulia Golinelli, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Cell Reports. Medicine|August 21, 2024
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stromaGiulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, et al.
Cytotherapy|May 12, 2025
Impact of mesenchymal stromal/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trialRoberto Tonelli, Francesca Pischiutta, Francesca Elice, et al.
Pageof 3